Proinflammatory cytokines and colorectal cancer – the impact of the stage

Colorectal cancer is one of the most often diagnosed malignant tumors. In Kazakhstan, high incidence of CC is registered along with other oncology diseases. Despite a significant progress in the disease treatment achieved lately, CC is still one of the major reasons of mortality due to oncologic pat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lyudmila Akhmaltdinova, Valentina Sirota, Dmitriy Babenko, Vera Zhumaliyeva, Irina Kadyrova, Mereke Maratkyzy, Aigerim Ibrayeva, Olga Avdienko
Format: article
Langue:EN
Publié: Termedia Publishing House 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/82dbb7b3d573415d9f0defb6f62ac224
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:Colorectal cancer is one of the most often diagnosed malignant tumors. In Kazakhstan, high incidence of CC is registered along with other oncology diseases. Despite a significant progress in the disease treatment achieved lately, CC is still one of the major reasons of mortality due to oncologic pathologies. To study the samples MilliplexMap HumanCirculationBiomarker panel in blood serum was used. XMap-based Fluorescence immunoassay was implemented, which comprised magnetic-bead-based simultaneous fluorescence detection of IL-6, IL-8, MIF, FGF-2, SCF, TGF, TNF, TRAIL analytes. Proinflammatory biomarker concentration detection at different CC stages allows to reveal the dynamics of inflammatory response of the organism to tumor and to use them (biomarkers) in further diagnostic and forecast in particular in CC. As a result of our study, it was found that IL-6, which showed the brightest reaction, due to its range of change and considerable shift already in the I stage can be recommended as a component of a complex diagnostic panel. Such markers as FGF2 and MIF also have a role in CC early stage detection.